Cooke Julie

Julie Cooke, Chief Human Resources Officer of Neurocrine Biosciences (NBIX), has demonstrated a clear selling bias in her recent insider transactions, with $2.32 million in total sales outweighing $399,851 in purchases across 33 reported trades. Her activity has been exclusively concentrated in NBIX shares, with all five of her most recent transactions being sales executed between January 31, 2025, and February 13, 2026. The largest single disposal occurred on February 13, 2026, when Cooke sold shares worth $667,517, followed by additional sales of $101,157 and $93,834 on the same day. Earlier transactions included a $135,651 sale on January 31, 2026, and a $92,201 disposition the previous day. Cooke’s only recorded buy occurred nearly a year earlier on May 16, 2025, when she acquired $399,851 worth of NBIX stock. Prior to that, she executed multiple sales in early 2025, including dispositions worth $140,045 and $125,979 on January 31, followed by an $82,792 sale on February 10 and two more sales totaling $181,129 on February 13. The pattern suggests a consistent reduction in her NBIX holdings over the past year, with no new purchases since mid-2025. The transactions appear to be primarily tied to equity awards (coded "M" and "A") and open-market sales (coded "S"), with the latter driving the overall net outflow.